The European Commission is continuing its efforts to secure COVID-19 products by signing supply deals with Gilead Sciences, Inc. for the antiviral Veklury (remdesivir) and with Janssen Pharmaceutica Inc. for a coronavirus vaccine.
Announced on 8 October, the joint procurement agreement (JPA) for Veklury will allow “rapid and equitable” access to the drug...








